WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the global pioneer in scientific advancement, unveils its groundbreaking Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)*, a next-gen Dynabeads platform with a revolutionary active release mechanism designed for both clinical trial and commercial manufacturing applications.
The cutting-edge active release feature of CTS Detachable Dynabeads employs a specialized release buffer, offering users the unprecedented ability to detach Dynabeads from target cells at any stage of the manufacturing process. This game-changing innovation not only drives manufacturing cost efficiency but also ensures exceptional cell purity, yield, and viability. These advancements hold the potential to expedite the delivery of life-transforming treatments, particularly for patients grappling with intricate diseases like blood cancers.
CTS Detachable Dynabeads offer unmatched process flexibility, seamless integration with automation, and scalability, thanks to their unique active release mechanism. This feature, tailored for cGMP and clinical applications, empowers users with precise control over their processes, enabling the consistent delivery of target cells with desired attributes for their therapy.
Moreover, it optimizes cell recovery, phenotype, and viability at various stages of the workflow. These advantages are paramount for cell therapy manufacturers seeking to scale up their operations while maintaining steadfast performance as they progress from process development to clinical trials and large-scale production.
The CTS Detachable Dynabeads platform seamlessly integrates into Thermo Fisher Scientific’s modular, enclosed, and automated cell therapy manufacturing workflow. When combined with Thermo Fisher Scientific’s Gibco Cell Therapy Systems (CTS) product lineup, including the Gibco CTS DynaCellect™ Magnetic Separation System, CTS Detachable Dynabeads trim manufacturing timelines by reducing the duration of post-cell isolation steps.
Tiffani Manolis, Vice President and General Manager of Cell Culture and Cell Therapy at Thermo Fisher Scientific, remarked, “While cell therapies are often a last resort for late-stage disease patients, we are committed to unlocking their potential as a primary treatment option. Our CTS Detachable Dynabeads platform ushers in a new era of cell therapy isolation and activation products, prioritizing patient safety and workflow control. These advancements mark a significant stride towards enabling our customers to commercialize affordable therapies swiftly, potentially saving more lives.”
The platform’s maiden offering is the CTS™ Detachable Dynabeads™ CD3/CD28 Kit, meticulously crafted to streamline the isolation and active targeting of T cells in a single, seamless process. This kit of isolation and activation reagents caters to both autologous and allogeneic manufacturing processes across various cell modalities. The CTS Detachable Dynabeads CD3/CD28 kit is available for immediate purchase.
Thermo Fisher’s CTS product range adheres to cGMP standards, aligns with pertinent cell therapy regulations, and provides traceability and regulatory documentation, facilitating a smooth transition from research to clinical trials and large-scale production.
To delve deeper into the world of Gibco CTS Detachable Dynabeads or inquire about CTS Detachable Dynabeads CD3/CD28 Kits, please visit thermofisher.com/ctsdynabeads.
For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.
About Thermo Fisher Scientific
At Thermo Fisher Scientific Inc., we proudly reign as the undisputed global champions of scientific advancement, boasting an impressive annual revenue that surpasses the $40 billion mark. Our noble Mission is nothing short of awe-inspiring: we exist to empower our cherished customers in their quest to cultivate a healthier, cleaner, and safer world.
Picture a world where the boundaries of science are pushed to their limits, where groundbreaking life sciences research is accelerated, intricate analytical puzzles are expertly solved, laboratory productivity soars to unprecedented heights, patient health is elevated through cutting-edge diagnostics, and life-altering therapies are born. That’s the world we tirelessly strive to create alongside our dedicated customers.
Our global dream team wields an unmatched arsenal of revolutionary technologies, all seamlessly intertwined with the convenience of procurement and the power of pharmaceutical services. We stand tall under the banner of our industry-leading brands, including the illustrious Thermo Scientific, the pioneering Applied Biosystems, the visionary Invitrogen, the trusted Fisher Scientific, the transformative Unity Lab Services, the world-class Patheon, and the trailblazing PPD.
Join us in this epic journey as we redefine the boundaries of what’s possible in the realm of science and innovation, shaping a future where scientific dreams become reality.